The Wellcome Trust/Cancer Research UK Gurdon Institute

What secrets lie hidden within the walls of a building dedicated to life’s smallest units? Here, at The Wellcome Trust/Cancer Research UK Gurdon Institute, those secrets are not just whispered, they are shouted from the rooftops in the language of discovery. The Gurdon Institute, nestled within the University of Cambridge, isn’t just a building. It’s a crucible where developmental biology and cancer biology meet. Founded in 1989, The Wellcome Trust/Cancer Research UK Gurdon Institute aimed to create a collaborative haven for scientists delving into these intertwined fields. Its initial funding came from two giants in medical research: the Wellcome Trust and Cancer Research UK. The institute’s very name honors Sir John Gurdon, a Nobel laureate whose groundbreaking work showed that mature cells could be reprogrammed. This discovery, a revolutionary concept in the 1960s, underpins today’s regenerative medicine. Sir John, a former director of The Wellcome Trust/Cancer Research UK Gurdon Institute, helped shape the institute’s open, collaborative atmosphere. The Gurdon Institute weathered a funding shift when the Wellcome Trust moved away from its core funding model. The institute, with the University of Cambridge’s support, embraced the challenge and refocused its research on human developmental and disease biology. It continues to draw brilliant minds from around the world, all driven by a shared passion for unraveling the mysteries of life and conquering disease. The Wellcome Trust/Cancer Research UK Gurdon Institute is more than a research center. It’s a testament to the power of collaboration, the pursuit of knowledge, and the enduring impact of a single, groundbreaking discovery.